After struggling for months with a Clostridioides difficile infection, Freda Pyles traveled from her home to rural Pennsylvania to Yale-New Haven Hospital in Connecticut for the therapy that ultimately healed her.
Freda Pyles, a resident of rural Pennsylvania, spent months with a recurrent Clostridioides difficile infection in 2021 into 2022; in this interview, she describes the therapy she received at Yale-New Haven Hospital that ultimately healed her.
Transcript
Is the treatment that ultimately worked for your Clostridioides difficile a fecal transplant?
Yes, it was the only thing that worked. And I felt good the very next day. The very next day, I got up and I said to my friends that we were staying with, I said, I feel good. I feel really good. I think I can go out and do something. And our friends that are both doctors said, are you sure? I said, yes, I feel good enough to go out and do something today. So my friend and I went and got a manicure. And I didn't have any problems that whole day. We got the manicure, we went to Trader Joe's, we went to Costco, we joined our husbands for dinner. And I felt good. And the next day we were leaving, and I felt good enough to get my car and drive. I just—it was, it was such a wonderful feeling. I said, I felt good like I have never felt good before.
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
The Supreme Court seems likely to reject a challenge to the abortion pill mifepristone; the FDA is inspecting far fewer pharmaceutical companies conducting clinical research; AstraZeneca has sued to block an Arkansas law that it said would unlawfully expand the 340B program to include for profit-pharmacy chains.
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen